Select therapeutic use:
Indications for VIRAZOLE:
Severe lower respiratory infections due to respiratory syncytial virus in hospitalized infants and young children.
Begin treatment preferably within first 3 days of infection. 20mg/mL as starting solution in drug reservoir for continuous aerosol administration for 12–18 hours per day for 3–7 days.
See literature. Monitor respiratory function, fluid status. Discontinue if pulmonary function deteriorates. Drug may precipitate in mechanical ventilator, causing dysfunction. Avoid unnecessary occupational exposure. Nursing mothers.
Pulmonary function deterioration, bronchospasm, pulmonary edema, hypoventilation, bacterial pneumonia, pneumothorax, apnea, ventilator dependence, atelectasis, cardiac arrest, hypotension, reticulocytosis, hemolytic anemia, rash, conjunctivitis.